High Post-treatment α-Fetoprotein Levels and Aspartate Aminotransferase-to-Platelet Ratio Index Predict Hepatocellular Carcinoma in Hepatitis C Virus Decompensated Cirrhotic Patients with Sustained Virological Response After Antiviral Therapy-Reference-Cited by-同舟云学术

High Post-treatment α-Fetoprotein Levels and Aspartate Aminotransferase-to-Platelet Ratio Index Predict Hepatocellular Carcinoma in Hepatitis C Virus Decompensated Cirrhotic Patients with Sustained Virological Response After Antiviral Therapy

Published:2017-08 Issue:8 Volume:37 Page:362-368
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Ji Fanpu¹²,Zhou Rui¹³,Wang Wenjun²,Bai Dan⁴,He Caini²,Cai Zhifang²,Shen Yuan⁵,Wang Shengbang²,Deng Hong²,Li Zongfang¹³

Affiliation:

1. Shaanxi Provincial Clinical Research Center for Hepatic & Splenic Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.

2. Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.

3. National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.

4. Department of Biochemistry and Molecular Biology, Medical College of Xi'an Jiaotong University, Xi'an, People's Republic of China.

5. Department of Epidemiology and Health Statistics, School of Public Health, Medical College of Xi'an Jiaotong University, Xi'an, People's Republic of China.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jir.2017.0040

Reference27 articles.

1. α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C

2. Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease

3. Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

4. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

5. Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis;Hepatology International;2024-07-05

2. The Age, Gamma-Glutamyl Transpeptidase and Platelet Index: A Novel Noninvasive Model for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Related Liver Cirrhosis;Journal of Hepatocellular Carcinoma;2022-10

3. HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis;Hepatology;2022-02-07

4. Non-invasive tests for the prediction of primary hepatocellular carcinoma;World Journal of Gastroenterology;2020-06-28

5. A Comparison of Splenic Pathologic Change and Immune Function in HBV-Related Portal Hypertension and Chinese Budd-Chiari Syndrome Patients with Hypersplenism;Viral Immunology;2020-03-01